-
My Account
In App
My Account
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 5 | 428.60 | 441.00 | 10 |
| 10 | 425.10 | 442.00 | 25 |
| 1 | 420.00 | 443.00 | 50 |
| 25 | 410.00 | 444.00 | 100 |
| 58 | 408.80 | 445.00 | 100 |
| 297 | Total | Total | 767 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 5 | 428.60 | 441.00 | 10 |
| 10 | 425.10 | 442.00 | 25 |
| 1 | 420.00 | 443.00 | 50 |
| 25 | 410.00 | 444.00 | 100 |
| 58 | 408.80 | 445.00 | 100 |
| 297 | Total | Total | 767 |
| Open | 430.00 |
| Previous Close | 431.85 |
| Volume | 5,584.00 |
| Value (Lacs) | 24.38 |
| VWAP | 434.01 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 2,675 |
| High | 437.10 |
| Low | 430.00 |
| UC Limit | 518.20 |
| LC Limit | 345.50 |
| 52 Week High | 581.90 |
| 52 Week Low | 281.10 |
| Face Value | 1.00 |
| All Time High | 581.90 |
| All Time Low | 22.50 |
| 20D Avg Volume | 142,096 |
| 20D Avg Delivery(%) | 44.90 |
| Book Value Per Share | 136.29 |
| Dividend Yield | 0.00 |
| TTM EPS See historical trend | 1.87 (+141.35% YoY) |
| TTM PE See historical trend | 233.50 (High PE) |
| P/B See historical trend | 3.21 (High P/B) |
| Sector PE | 40.00 |
*Delayed by 20 seconds.
Stock Score
Get detailed analysis with Moneycontrol Stock Insights.
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
9 out of 17 years Panacea Biotec has given positive returns in November.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| November | 34.11% (2024) | 14.23% | -10.73% (2019) | -5.07% | 5.15% |
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y Jun 03 2025 12:39 PM
Stocks to Watch Today: Tata Consumer Products, BPCL, Adani Green Energy, Panacea Biotec, Thyrocare, Bajaj Housing, LTIMindtree in focus on 24 April Apr 24 2025 01:12 AM
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y Mar 04 2025 01:33 PM
Panacea Biotec shares hit 5% UC on UNICEF supply order worth Rs 127 crore Dec 26 2024 11:55 AM
Panacea Biotec to supply vaccine worth Rs 127.20 crore The Central Medical Services Society, Ministry of Health and Family Welfare, Government of India CMSS has accepted the companys offer for supply of bivalent oral polio vaccine bOPV against the tender. As per the LOA, the company will supply the vaccine worth Rs 127.20 Crore in several tranches over a period of 90 - 480 days from the date of issuance of LOA. View more
Posted by : kamal20
Repost this message
Panacea Biotec to supply vaccine worth Rs 127.20 crore The Central Medical Services Society, Ministry of Health and Family Welfare, Government of India CMSS has accepted the companys offer for supply of bivalent oral polio vaccine bOPV against the tender. As per the LOA, the company will supply the vaccine worth Rs 127.20 Crore in several tranches over a period of 90 - 480 days from the date of issuance of LOA.
panacea biotec gets loa from unicef panacea biotec has received a letter of award from unicef for a long-term agreement for supply of bivalent oral polio vaccine bopv to unicef starting from 1 st april 2026 to 31st march 2030. View more
Posted by : kamal20
Posted by : The Fixed Income
Repost this message
Steady Returns Backed by the State of Maharashtra ✔️ Coupon: 8.42% ✔️ Tenor: 2y 8m (Maturity: 01/Aug/2028) G-Sec | Listed | Sovereign-Backed Enjoy peace of mind with a state-backed investment that offers assured returns and low risk — the perfect mix of stability and steady income for your portfolio. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJhc1p3PT0=/842-maharashtra-sdl-2028?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 800000 | Price 453.02 | % Traded 1.31 |
| Qty 316410 | Price 299.18 | % Traded 0.50 |
| Qty 316410 | Price 301.11 | % Traded 0.50 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Panacea Biotec | 433.00 | 0.27 | 2,652.16 | 231.55 | 3.18 | -1.00 | 20.56 | -8 | 559 | 0.03 |
| Sun Pharma | 1,706.60 | 0.01 | 409,470.51 | 39.48 | 5.67 | 15.13 | -5.66 | 10,980 | 52,578 | 0.03 |
| Divis Labs | 6,790.00 | -0.21 | 180,253.17 | 78.16 | 12.04 | 14.63 | 15.05 | 2,191 | 9,360 | 0.00 |
| Torrent Pharma | 3,627.00 | -0.04 | 122,754.16 | 61.32 | 16.36 | 25.17 | 13.32 | 1,911 | 11,516 | 0.40 |
| Cipla | 1,509.60 | -0.13 | 121,941.14 | 22.41 | 3.91 | 16.90 | -4.73 | 5,291 | 27,547 | 0.00 |
Sharpest Opinions & Actionable Insights 
Exclusive Webinars 
Research & Expert Technical Analysis 
